AstraZeneca PLC, Johnson & Johnson Drugs for Schizophrenia May Exacerbate Loss of Brain Tissue, Study Finds

Bloomberg -- Anti-psychotic drugs from AstraZeneca Plc and Johnson & Johnson may lead to loss of brain tissue or exacerbate declines in brain volume caused by schizophrenia, a study in the Archives of General Psychiatry found.

Back to news